5-Bromo-1,4-dimethyl-1H-pyrazole

Catalog No.: 
ACUXZL091
CAS No.: 
1393583-34-0
Molecular Formula: 
C5H7BrN2
Molecular Weight: 
175.03
5-Bromo-1,4-dimethyl-1H-pyrazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$121.00In stockInquiry
250mg97%$201.00In stockInquiry
1g97%$541.00In stockInquiry
5g97%$1605.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Bromo-1,4-dimethyl-1H-pyrazole
IUPAC Name5-bromo-1,4-dimethyl-1H-pyrazole
MDL No.MFCD22547955
Molecular FormulaC5H7BrN2
Molecular Weight175.03
SMILESCC1=C(Br)N(C)N=C1
InChI KeyUKCYRDDMLBDMPK-UHFFFAOYSA-N
Synonym5-BROMO-1,4-DIMETHYL-1H-PYRAZOLE | 1393583-34-0 | 5-bromo-1,4-dimethylpyrazole | MFCD22547955 | 1H-Pyrazole, 5-bromo-1,4-dimethyl- | SCHEMBL9027327 | AKOS024056756 | AB84867 | SB12842 | AS-51669 | SY099053 | CS-0050654 | EN300-645983 | P13239
CAS No.1393583-34-0
PubChem CID19757100

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACUXZL091 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACEZIG709 route compound structure diagram
    ACEZIG7095932-20-7In Stock
  4. Then
  5. ACUXZL091 route product structure diagram
    ACUXZL0911393583-34-0In Stock
Inquiry

2. ACUXZL091 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACUXZL091 route product structure diagram
    ACUXZL0911393583-34-0In Stock
Inquiry

3. ACUXZL091 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACUXZL091 route product structure diagram
    ACUXZL0911393583-34-0In Stock
Inquiry

Comments (0)